Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
  • The Cook Central Office, 36 South Wabash Avenue, Chicago, will close 02/03/2025.  The new Cook Central Office will open at 115 South LaSalle, Chicago, for in-person service on 02/10/2025.  
  • ​UPDATE: The State Disbursement Unit (SDU) is processing all payments received. To verify the status of your payment, please log into the SDU parent portal or contact the SDU Customer Service Call Center at 877.225.7077.  For SDU business hours, click here.
Elizabeth M. Whitehorn, Director

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 4, 2009

Drug Name Review Type Class Manufacturer
Sancuso New Drug Initial Review Antiemetic ProStrakan
Moxatag New Drug Initial Review Antibiotic MiddleBrook
Astepro New Drug Initial Review Nasal Preprarations Meda
Trilipix New Drug Initial Review Lipotropics � Other Abbott
Stavzor New Drug Initial Review Anticonvulsant Noven
Janumet New Drug Initial Review Diabetes Merck
Banzel New Drug Initial Review Anticonvulsant Eisai
Tekturna HCT New Drug Initial Review Direct Renin Inhibitor Novartis
Letairis New Drug Appeal Pulmonary Arterial Hypertension Gilead
Megace ES New Drug Appeal Progestin Par
Bystolic New Drug Appeal Beta-Blocker Forest
Pristiq New Drug Appeal SNRI Antidepressant Wyeth
Keppra XR New Drug Appeal Anticonvulsant UCB
Exforge New Drug Appeal Antihypertensive Combination Novartis
Tekturna New Drug Appeal Direct Renin Inhibitor Novartis